Machine learning is reshaping the way portfolios are built, monitored, and adjusted. Investors are no longer limited to ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

A new orchestration approach, called Orchestral, is betting that enterprises and researchers want a more integrated way to ...

Recursion Pharmaceuticals Inc has faced significant challenges in its financial performance, highlighted by a sharp decline in revenue growth, which fell to -32.98% in Q3 2025 from +30.14% in Q2 2025.

Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.